Eledon Pharmaceuticals In... (ELDN)
3.99
-0.16 (-3.86%)
At close: Mar 03, 2025, 3:59 PM
3.99
0.00%
After-hours: Mar 03, 2025, 03:59 PM EST
Eledon Pharmaceuticals Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -1.1K | -0.37 | -1.89 | -0.98 | -0.38 | -1.02 | -1.45 | -0.09 | -4.35 | -4.09 | -23.21 | -37.82 |
| PEG Ratio | 10.99 | -0.00 | 0.02 | 0.02 | 0.13 | 0.02 | 0.01 | -0.00 | 0.10 | -0.02 | -0.37 | n/a |
| PS Ratio | n/a | n/a | n/a | 186.27 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 6.15K | 0.39 | 0.40 | 0.12 | 0.72 | 0.99 | 0.98 | 0.13 | 3.18 | 0.92 | -6.6 | -9.15 |
| P/FCF Ratio | -1.12K | -1.15 | -2.26 | -1.47 | -0.49 | -1.21 | -1.27 | -0.09 | -4.69 | -4.51 | -23.54 | -39.07 |
| P/OCF Ratio | -1.12K | -1.15 | -2.26 | -1.47 | -0.49 | -1.21 | -1.27 | -0.09 | -4.75 | -4.51 | -23.58 | -39.1 |
| OCF/S Ratio | n/a | n/a | n/a | -126.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.05 | 0.01 | 0.00 | 0.00 | 0.03 | n/a | n/a | 0.13 | n/a | n/a | n/a | n/a |
| Quick Ratio | 14.41 | 9.19 | 20.07 | 46.05 | 6.88 | 5.63 | 13.19 | 10.48 | 10.90 | 25.34 | 14.57 | 5.91 |
| Current Ratio | 14.41 | 9.19 | 20.07 | 46.57 | 7.54 | 5.63 | 13.19 | 10.48 | 10.90 | 25.34 | 14.57 | 5.91 |
| Asset Turnover | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -260.12 | n/a | n/a | n/a |
| Return on Equity (ROE) | -5.59 | -1.04 | -0.21 | -0.12 | -1.89 | -0.97 | -0.67 | -1.41 | -0.73 | -0.23 | 0.28 | 0.24 |
| Return on Assets (ROA) | -0.45 | -0.94 | -0.2 | -0.12 | -1.64 | -0.83 | -0.63 | -1.28 | -0.66 | -0.22 | -0.49 | -0.81 |
| Return on Capital (ROIC) | -0.5 | 0.10 | -0.22 | -0.09 | -1.67 | -0.97 | -0.67 | -1.42 | -0.73 | -0.23 | -0.52 | -0.97 |
| Dividend Yield | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | -52.5% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | -19.01K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | -19.35K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | -15.39K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | -12.68K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | -19.19K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |